Brief: Microba Life Sciences Posts A$4.81 Mln Q4 Fy24 Unaudited Revenue
25/07/2024 03:45
July 25 (Reuters) - Microba Life Sciences Ltd MAP.AX :
* A$4.81M IN Q4 FY24 UNAUDITED REVENUE, UP 20.2% QOQ
Further company coverage: MAP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microba Life Sciences
See all newsBrief: Genetic Signatures Says Microba Shareholders To Hold 60% Of GSS On Merger
Brief: Microba Life Sciences Announces Placement Via Two Tranches
Brief: Microba Life Sciences Appoints Geoffrey Cockerill As Interim CEO
Australia's Genetic Signatures climbs on potential merger with Microba
Brief: Microba Life Sciences Says Microba Signs Multi-Year Synlab Agreement